ICP
TEVA icon

Interchange Capital Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Interchange Capital Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,600
Closed -$82K – 998
2020
Q4 		$82K Buy
+8,600
New +$82.4K 0.04% 331

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Interchange Capital Partners's TEVA Position: Q1 2021 in Review

Interchange Capital Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2021, closing a stake of 8,600 shares — an estimated $82K sold.

Interchange Capital Partners first reported a position in TEVA in Q4 2020 and held it in 1 quarter. The position peaked at $82K in Q4 2020. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

  • Interchange Capital Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 8,600 Teva Pharmaceutical Industries Limited shares in Q1 2021, an estimated $82K.
  • Interchange Capital Partners first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's Teva Pharmaceutical Industries Limited position peaked at $82K in Q4 2020.
  • 451 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.